35.47
5.38%
1.81
Handel nachbörslich:
34.51
-0.96
-2.71%
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN
US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St
AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey
AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St
Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
AtriCure price target raised to $36 from $32 at Oppenheimer - MSN
AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India
AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat
AtriCure (NASDAQ:ATRC) Given New $40.00 Price Target at Needham & Company LLC - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat
AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance
AtriCure: Q3 Earnings Snapshot - The Washington Post
AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com
AtriCure Reports Third Quarter 2024 Financial Results - StockTitan
Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure to Participate in the UBS Global Healthcare Conference - StockTitan
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Scheduled to Post Earnings on Tuesday - MarketBeat
Cardiac Ablation Technology Market Analysis By Top Keyplayers - openPR
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure Inc (ATRC) Trading Down 2.91% on Oct 17 - GuruFocus.com
SG Americas Securities LLC Buys New Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device - Yahoo Finance
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management - BioSpace
AtriCure launches new CryoSphere Max cryoablation probe - Mass Device
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago - Yahoo Finance
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe - Yahoo Finance
Atrial Fibrillation Market Rapid Growth, Challenges, - openPR
Atrial Appendage Occluder Market Set to Soar to USD 8,193.0 Million by 2033 at a 23.6% of CAGR - Future Market Insights
Is Atricure Inc (ATRC) a threat to investors? - US Post News
Transcatheter Embolization and Occlusion Devices Market Analysis To 2031 | Inc, AtriCure, Stryker Corporation, Merit Medical System, Pfizer, Inc, Edwards – Times-BD24 - Times-BD24
Where are the Opportunities in (ATRC) - Stock Traders Daily
There is no doubt that Atricure Inc (ATRC) ticks all the boxes. - SETE News
Market Insight: Atricure Inc (ATRC)’s Notable Drop, Closing at 27.07 - The Dwinnex
Atrial Fibrillation Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News
AtriCure to Announce Third Quarter 2024 Financial Results - StockTitan
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Millennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):